Analysis of travel burden and travel support among patients treated at a comprehensive cancer center in the Southeastern United States.
Cancer
Neighborhood socioeconomic deprivation
Social determinants of health
Travel burden
Travel support
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
22 Jun 2024
22 Jun 2024
Historique:
received:
03
12
2023
accepted:
13
06
2024
medline:
22
6
2024
pubmed:
22
6
2024
entrez:
21
6
2024
Statut:
epublish
Résumé
Travel burden leads to worse cancer outcomes. Understanding travel burden and the level and types of travel support provided at large cancer centers is critical for developing systematic programs to alleviate travel burden. This study analyzed patients who received travel assistance, including their travel burden, types and amount of travel support received, and factors that influenced these outcomes. We analyzed 1063 patients who received travel support from 1/1/2021 to 5/1/2023 at Winship Cancer Institute, in which ~18,000 patients received cancer care annually. Travel burden was measured using distance and time to Winship sites from patients' residential address. Travel support was evaluated using the monetary value of total travel support and type of support received. Patients' sociodemographic and clinical factors were extracted from electronic medical records. Area-level socioeconomic disadvantage was coded by the Area Deprivation Index using patient ZIP codes. On average, patients traveled 57.2 miles and 67.3 min for care and received $74.1 in total for travel support. Most patients (88.3%) received travel-related funds (e.g., gas cards), 5% received direct rides (e.g., Uber), 3.8% received vouchers for taxi or public transportation, and 3% received combined travel support. Male and White had longer travel distance and higher travel time than female and other races, respectively. Patients residing in more disadvantaged neighborhoods had an increased travel distance and travel time. Other races and Hispanics received more travel support ($) than Black and White patients or non-Hispanics. Patients with higher travel distance and travel time were more like to receive travel-related financial support. Among patients who received travel support, those from socioeconomically disadvantaged neighborhoods had greater travel burden. Patients with greater travel burden were more likely to receive travel funds versus other types of support. Further understanding of the impact of travel burden and travel support on cancer outcomes is needed.
Identifiants
pubmed: 38907006
doi: 10.1007/s00520-024-08656-3
pii: 10.1007/s00520-024-08656-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
451Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L (2015) Distance as a barrier to cancer diagnosis and treatment: review of the literature. Oncologist 20:1378–1385
pubmed: 26512045
pmcid: 4679078
doi: 10.1634/theoncologist.2015-0110
Chen E, Deshane A, Damico N, Kharouta M, Kim U, Kemmann M, Kyasaram R, Wu AK, Biswas T, Dorth J (2023) An analysis of cancer center–provided rideshare utilization for radiation therapy. J Am Coll Radiol 20:40–50
pubmed: 36581084
doi: 10.1016/j.jacr.2022.12.007
Ohri N, Rapkin BD, Guha C, Kalnicki S, Garg M (2016) Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center. Int J Radiat Oncol Biol Phys 95:563–570
pubmed: 27020104
doi: 10.1016/j.ijrobp.2016.01.043
Lara PN Jr, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O’Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS (2001) Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 19:1728–1733
pubmed: 11251003
doi: 10.1200/JCO.2001.19.6.1728
McCaskill-Stevens W, McKinney MM, Whitman CG, Minasian LM (2005) Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience. J Clin Oncol 23:5247–5254
pubmed: 16051967
doi: 10.1200/JCO.2005.22.236
Rocque GB, Williams CP, Miller HD, Azuero A, Wheeler SB, Pisu M, Hull O, Rocconi RP, Kenzik KM (2019) Impact of travel time on health care costs and resource use by phase of care for older patients with cancer Journal of Clinical Oncology: official journal of the American Society of. Clin Oncol 37:1935–1945
Longacre CF, Neprash HT, Shippee ND, Tuttle TM, Virnig BA (2020) Evaluating travel distance to radiation facilities among rural and urban breast cancer patients in the medicare population. J Rural Health 36:334–346
pubmed: 31846127
doi: 10.1111/jrh.12413
Lin CC, Bruinooge SS, Kirkwood MK, Hershman DL, Jemal A, Guadagnolo BA, Yu JB, Hopkins S, Goldstein M, Bajorin D, Giordano SH, Kosty M, Arnone A, Hanley A, Stevens S, Olsen C (2016) Association between geographic access to cancer care and receipt of radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 94(4):719–728
pubmed: 26972644
doi: 10.1016/j.ijrobp.2015.12.012
Labban M, Chen C-R, Frego N, Nguyen D-D, Lipsitz SR, Reich AJ, Rebbeck TR, Choueiri TK, Kibel AS, Iyer HS, Trinh Q-D (2023) Disparities in travel-related barriers to accessing health care from the 2017 national household travel survey. JAMA Network Open 6(7):e2325291
Probst JC, Laditka SB, Wang J-Y, Johnson AO (2007) Effects of residence and race on burden of travel for care: cross sectional analysis of the 2001 US National Household Travel Survey. BMC Health Serv Res 7:40
pubmed: 17349050
pmcid: 1851736
doi: 10.1186/1472-6963-7-40
Meilleur A, Subramanian S, Plascak JJ, Fisher JL, Paskett ED, Lamont EB (2013) Rural residence and cancer outcomes in the United States: issues and challenges. Cancer Epidemiol Biomarkers Prev 22:1657–1667
pubmed: 24097195
doi: 10.1158/1055-9965.EPI-13-0404
Flytkjær Virgilsen L, Møller H, Vedsted P (2019) Cancer diagnostic delays and travel distance to health services: a nationwide cohort study in Denmark. Cancer Epidemiol 59:115–122
pubmed: 30738284
doi: 10.1016/j.canep.2019.01.018
Sauerzapf VA, Jones AP, Haynes R, Crawford SM, Forman D (2008) Travel time to radiotherapy and uptake of breast-conserving surgery for early stage cancer in Northern England. Health Place 14:424–433
pubmed: 17951094
doi: 10.1016/j.healthplace.2007.09.002
Manning M, Marquez R, Woodruff H, Hislop B, Sintay BJ (2020) The impact of rideshare transportation in radiation oncology. Int J Radiat Oncol Biol Phys 108:S99–S100
doi: 10.1016/j.ijrobp.2020.07.2274
National Cancer Institute (2022) Cancer disparities. In: Understanding cancer. https://www.cancer.gov/about-cancer/understanding/disparities . Accessed 10 May 2024
Jiang C, Yabroff KR, Deng L, Wang Q, Perimbeti S, Shapiro CL, Han X (2022) Self-reported transportation barriers to health care among US cancer survivors. JAMA Oncol 8:775–778
pubmed: 35323841
pmcid: 8949758
doi: 10.1001/jamaoncol.2022.0143
Probst JC, Laditka SB, Wang J-Y, Johnson AO (2007) Effects of residence and race on burden of travel for care: cross sectional analysis of the 2001 US National Household Travel Survey. BMC Health Serv Res 7:40
pubmed: 17349050
pmcid: 1851736
doi: 10.1186/1472-6963-7-40
Obrochta CA, Parada H Jr, Murphy JD, Nara A, Trinidad D, Araneta MRH, Thompson CA (2022) The impact of patient travel time on disparities in treatment for early stage lung cancer in California. PLoS One 17:e0272076
Chaiyachati KH, Hubbard RA, Yeager A, Mugo B, Lopez S, Asch E, Shi C, Shea JA, Rosin R, Grande D (2018) Association of rideshare-based transportation services and missed primary care appointments: a clinical trial. JAMA Intern Med 178:383–389
pubmed: 29404572
doi: 10.1001/jamainternmed.2017.8336
Zhang Q, Wang Y, Tao S, Bilsborrow RE, Qiu T, Liu C, Sannigrahi S, Li Q, Song C (2020) Divergent socioeconomic-ecological outcomes of China's Conversion of Cropland to Forest Program in the subtropical mountainous area and the semi-arid Loess Plateau. Ecosyst Serv 45:101167
Starbird LE, DiMaina C, Sun C-A, Han H-R (2019) A systematic review of interventions to minimize transportation barriers among people with chronic diseases. J Community Health 44:400–411
pubmed: 30206755
pmcid: 6450539
doi: 10.1007/s10900-018-0572-3
Singh GK, Siahpush M (2002) Increasing inequalities in all-cause and cardiovascular mortality among US adults aged 25–64 years by area socioeconomic status, 1969–1998. Int J Epidemiol 31:600–613
Singh GK (2003) Area deprivation and widening inequalities in US mortality, 1969–1998. Am J Publ Health 93:1137–1143
doi: 10.2105/AJPH.93.7.1137
Singh GK, Miller BA, Hankey BF, Edwards BK (2004) Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 101:1051–1057
pubmed: 15329915
doi: 10.1002/cncr.20467
Bai J, Pugh SL, Eldridge R, Yeager KA, Zhang Q, Lee WR, Shah AB, Dayes IS, D’Souza DP, Michalski JM, Efstathiou JA, Longo JM, Pisansky TM, Maier JM, Faria SL, Desai AB, Seaward SA, Sandler HM, Cooley ME, Bruner DW (2023) Neighborhood deprivation and rurality associated with patient-reported outcomes and survival in men with prostate cancer in NRG oncology RTOG 0415. Int J Radiat Oncol Biol Phys 116:39–49
pubmed: 36736921
pmcid: 10106367
doi: 10.1016/j.ijrobp.2023.01.035
Bai J, Qiu W, Yasui Y, Barandouzi Z, Kadan-Lottick NS, Leisenring WM, Webster C, Hudson MM, Ness KK, Zhang Q, Howell CR, King TZ, Huang I-C, Armstrong GT, Krull KR (2023) Social determinants of health and neurocognitive and psychosocial outcomes in adult childhood cancer survivors: A report from the childhood cancer survivor study (CCSS). J Clin Oncol 41:12084–12084
doi: 10.1200/JCO.2023.41.16_suppl.12084
Kind AJ, Jencks S, Brock J, Yu M, Bartels C, Ehlenbach W, Greenberg C, Smith M (2014) Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med 161:765–774
pubmed: 25437404
pmcid: 4251560
doi: 10.7326/M13-2946
Durfey SNM, Kind AJH, Buckingham WR, DuGoff EH, Trivedi AN (2019) Neighborhood disadvantage and chronic disease management. Health Serv Res 54(Suppl 1):206–216
pubmed: 30468015
doi: 10.1111/1475-6773.13092
Gordon SH, Lee Y, Ndumele CD, Vivier PM, Gutman R, Swaminathan S, Gadbois EA, Shield RR, Kind AJH, Trivedi AN (2018) The impact of Medicaid managed care plan type on continuous Medicaid enrollment: a natural experiment. Health Serv Res 53:3770–3789
pubmed: 29952062
pmcid: 6153165
doi: 10.1111/1475-6773.13000
Sheets L, Petroski GF, Jaddoo J, Barnett Y, Barnett C, Kelley LEH, Raman V, Kind AJH, Parker JC (2018) The effect of neighborhood disadvantage on diabetes prevalence. AMIA Annu Symp Proc 2017:1547–1553
pubmed: 29854224
pmcid: 5977699
Kind AJH, Buckingham WR (2018) Making neighborhood-disadvantage metrics accessible — the neighborhood Atlas. N Engl J Med 378:2456–2458
pubmed: 29949490
pmcid: 6051533
doi: 10.1056/NEJMp1802313
Gould-Werth A, Griffin J, Murphy A (2018) Developing a new measure of transportation insecurity: an exploratory factor analysis Survey. Practice 11:1–34
Resio BJ, Chiu AS, Hoag JR, Brown LB, White M, Omar A, Monsalve A, Dhanasopon AP, Blasberg JD, Boffa DJ (2018) Motivators, barriers, and facilitators to traveling to the safest hospitals in the united states for complex cancer surgery. JAMA Network Open 1:e184595–e184595
pubmed: 30646367
pmcid: 6324377
doi: 10.1001/jamanetworkopen.2018.4595
Bruner DW, Pugh SL, Yeager KA, Bruner J, Curran W Jr (2015) Cartographic mapping and travel burden to assess and develop strategies to improve minority access to national cancer clinical trials International Journal of Radiation Oncology. Biology, Physics 93:702–709
Fraze TK, Brewster AL, Lewis VA, Beidler LB, Murray GF, Colla CH (2019) Prevalence of screening for food insecurity, housing instability, utility needs, transportation needs, and interpersonal violence by US physician practices and hospitals. JAMA Network Open 2:e1911514–e1911514
pubmed: 31532515
pmcid: 6752088
doi: 10.1001/jamanetworkopen.2019.11514
Graboyes EM, Chaiyachati KH, Sisto Gall J, Johnson W, Krishnan JA, McManus SS, Thompson L, Shulman LN, Yabroff KR (2022) Addressing transportation insecurity among patients with cancer. J Natl Cancer Inst 114:1593–1600
pubmed: 36130286
pmcid: 9745432
doi: 10.1093/jnci/djac134
Razon N, Gottlieb L (2022) Content analysis of transportation screening questions in social risk assessment tools: are we capturing transportation insecurity? J Am Board Fam Med 35:400–405
pubmed: 35379729
doi: 10.3122/jabfm.2022.02.210256
Chaiyachati KH, Krause D, Sugalski J, Graboyes EM, Shulman LN (2023) A survey of the national comprehensive cancer network on approaches toward addressing patients’ transportation insecurity. J Natl Compr Canc Netw 21:21–26
pubmed: 36634609
pmcid: 9888481
doi: 10.6004/jnccn.2022.7073
Syed ST, Gerber BS, Sharp LK (2013) Traveling towards disease: transportation barriers to health care access. J Community Health 38:976–993
pubmed: 23543372
pmcid: 4265215
doi: 10.1007/s10900-013-9681-1
Wallace R, Hughes-Cromwick P, Mull H, Khasnabis S (2005) Access to health care and nonemergency medical transportation: two missing links. Transp Res Rec 1924:76–84
doi: 10.1177/0361198105192400110
Stoyanov DS, Conev NV, Donev IS, Tonev ID, Panayotova TV, Dimitrova-Gospodinova EG (2022) Impact of travel burden on clinical outcomes in lung cancer. Support Care Cancer 30:5381–5387
pubmed: 35288785
doi: 10.1007/s00520-022-06978-8
Etminani-Ghasrodashti R, Kan C, Mozaffarian L (2021) Investigating the role of transportation barriers in cancer patients’ decision making regarding the treatment process. Transp Res Rec 2675:175–187
doi: 10.1177/0361198121991497
Guidry JJ, Aday LA, Zhang D, Winn RJ (1997) Transportation as a barrier to cancer treatment. Cancer Pract 5:361–366
pubmed: 9397704
Latif A, Stensland KD, Hendricks R, Moshier EL, Godbold JH, Oh WK, Galsky MD (2013) Cancer clinical trial accessibility in the United States: an analysis of travel distance. J Clin Oncol 31(15_suppl):6540–6540
Vetterlein MW, Löppenberg B, Karabon P, Dalela D, Jindal T, Sood A, Chun FK, Trinh QD, Menon M, Abdollah F (2017) Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer. Cancer 123:3241–3252
pubmed: 28472547
doi: 10.1002/cncr.30744
Fujiwara T, Ogura K, Healey J (2021) Greater travel distance to specialized facilities is associated with higher survival for patients with soft-tissue sarcoma: US nationwide patterns. PloS One 16:e0252381
Bayne A, Siegfried A, Beck LF, Freund K (2021) Barriers and facilitators of older adults' use of ride share services. J Transp Health 21:101055
Borno HT, Zhang L, Zhang S, Lin TK, Skafel A, Nieves E, Dornsife D, Johnson R, Rhoads K, Small E, Spicer D (2022) Implementation of a multisite financial reimbursement program in cancer clinical trials integrated with patient navigation: a pilot randomized clinical trial. JCO Oncol Pract 18:e915–e924
pubmed: 35196064
pmcid: 9191303
doi: 10.1200/OP.21.00328
Guerra CE, Sallee V, Hwang W-T, Bryant B, Washington AL, Takvorian SU, Schnoll R, Glanz K, Cohen RB, Nathanson KL, Vonderheide RH (2021) Accrual of Black participants to cancer clinical trials following a five-year prospective initiative of community outreach and engagement. J Clin Oncol 39:100–100
doi: 10.1200/JCO.2021.39.15_suppl.100
Vais S, Siu J, Maru S, Abbott J, St. Hill I, Achilike C, Wu W-J, Adegoke TM, Steer-Massaro C (2020) Rides for refugees: a transportation assistance pilot for women’s health. J Immigr Minor Health 22:74–81
Powers BW, Rinefort S, Jain SH (2016) Nonemergency medical transportation: delivering care in the era of Lyft and Uber. JAMA 316:921–922
pubmed: 27599325
doi: 10.1001/jama.2016.9970
American Hospital Association (2023) The financial stability of America’s hospitals and health systems is at risk as the costs of caring continue to rise. In: Cost of caring. https://www.aha.org/costsofcaring . Accessed 10 May 2024